Shinichi Komiyama

8PUBLICATIONS
28CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Psychosocial aspects of childbirth and perinatal mental healthChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 09, 2024
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida

|Oct 30, 2021
Efficacy and safety of standard of care with/without bevacizumab for platinum-resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023.

Tadahiro Shoji, Takayuki Enomoto, Masakazu Abe

|Dec 16, 2020
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.

Aikou Okamoto, Eiji Kondo, Toshiaki Nakamura

|Aug 08, 2020
Conservative management of uterine artery pseudoaneurysm occurring during treatment of gestational trophoblastic disease: A case report.

Eijiro Hayata, Shinichi Komiyama, Masaru Nagashima

|Feb 10, 2019
Bevacizumab Plus Direct Oral Anticoagulant Therapy in Ovarian Cancer Patients with Distal Deep Vein Thrombosis.

Shinichi Komiyama, Masaru Nagashima, Tomoko Taniguchi

|Sep 13, 2018
Safety and efficacy of neoadjuvant chemotherapy containing bevacizumab and interval debulking surgery for advanced epithelial ovarian cancer: A feasibility study.

Shinichi Komiyama, Tsuyoki Kugimiya, Kaneyuki Kubushiro

Pageof 2

Frequent Collaborators

2 joint publications

Motoki Matsuura

2 joint publications

Aikou Okamoto

2 joint publications

Eiji Kondo

2 joint publications

Toshiaki Nakamura